Category: Accesswire

  • European Medicines Agency’s Committee for Medicinal Products for Human Use Adopts Positive Opinion Recommending Marketing Authorization of mCOMBRIAX, Moderna’s mRNA Combination Vaccine Against Influenza and COVID-19

    mCOMBRIAX is the world’s first flu plus COVID combination vaccine to receive a positive CHMP opinion recommending marketing authorization and represents Moderna’s fourth vaccine to receive a positive CHMP opinion

    mCOMBRIAX will be made available in the European Union, subject to final European Commission authorization and national regulatory and access procedures

    CAMBRIDGE, MASSACHUSETTS / ACCESS Newswire / February 27, 2026 / Moderna, Inc. (NASDAQ:MRNA) today announced that the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) has adopted a positive opinion recommending marketing authorization in the European Union for mCOMBRIAX® (mRNA-1083), Moderna’s combination vaccine indicated for active immunization for the prevention of influenza and COVID-19 caused by SARS-CoV-2 in individuals 50 years of age and older.

    “The CHMP’s positive opinion represents an important milestone for respiratory virus vaccination and for Moderna, with the introduction of the world’s first flu plus COVID combination vaccine. If approved, this would be Moderna’s fourth marketed product in Europe,” said Stéphane Bancel, Chief Executive Officer of Moderna. “Combination vaccines have the potential to simplify vaccination and support improved health outcomes. We appreciate the EMA’s rigorous scientific review.”

    mCOMBRIAX builds on the advances of mNEXSPIKE®, Moderna’s COVID-19 vaccine, and mRNA-1010, Moderna’s investigational seasonal influenza vaccine, which has been accepted for review in the United States, the European Union, Canada and Australia.

    The CHMP opinion is supported by results from the pivotal Phase 3 clinical trial (ClinicalTrials.gov Identifier: NCT06097273), a randomized, observer-blind, active-controlled study evaluating the safety, reactogenicity and immunogenicity of mRNA-1083 in two independent age cohorts of approximately 4,000 adults each. One cohort included adults 65 years of age and older and compared mRNA-1083 to co-administered Fluzone HD® (licensed in the European Union as Efluelda®), a high-dose influenza vaccine, and Spikevax®, Moderna’s licensed COVID-19 vaccine. The second cohort included adults 50 to 64 years of age and compared mRNA-1083 to co-administered Fluarix®, a standard-dose influenza vaccine, and Spikevax.

    All primary endpoints demonstrating the non-inferiority of immune responses were met. Following a single dose, mRNA-1083 elicited statistically significantly higher immune responses against three influenza virus strains (A/H1N1, A/H3N2 and B/Victoria) and against SARS-CoV-2 in both age cohorts. The B/Yamagata strain, which is no longer recommended for inclusion in seasonal influenza vaccines, was the only strain for which a statistically significantly higher immune response was not observed for adults 65 years of age and older compared to the co-administered licensed comparator vaccines.[1]

    mRNA-1083 demonstrated an acceptable safety and tolerability profile. The majority of solicited adverse reactions were grade 1 or 2 in severity and consistent with the licensed vaccines used in the trial.

    Following the CHMP’s positive opinion, the European Commission will consider the recommendation and is expected to adopt a final decision on marketing authorization. Once the European Commission approves a product, the marketing authorization is valid in all EU Member States as well as in the European Economic Area (EEA) countries of Iceland, Liechtenstein and Norway. Upon European Commission approval, Moderna will work with national regulatory and health authorities to support local access and implementation.

    About Moderna

    Moderna is a pioneer and leader in the field of mRNA medicine. Through the advancement of its technology platform, Moderna is reimagining how medicines are made to transform how we treat and prevent diseases. Since its founding, Moderna’s mRNA platform has enabled the development of vaccines and therapeutics across infectious diseases, cancer, rare diseases and more.

    With a global team and a unique culture, driven by the company’s values and mindsets, Moderna’s mission is to deliver the greatest possible impact to people through mRNA medicines. For more information about Moderna, please visit modernatx.com and connect with us on X, Facebook, Instagram, YouTube and LinkedIn.

    mCOMBRIAX®, mNEXSPIKE® and Spikevax® are registered trademarks of Moderna.
    Fluzone HD® and Efluelda® are registered trademarks of Sanofi Pasteur.
    Fluarix® is a registered trademark of the GlaxoSmithKline group of companies.

    Forward-Looking Statements

    This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, as amended, including statements regarding: the availability of mCOMBRIAX in Europe; the potential of combination vaccines to simplify vaccination and support improved health outcomes; potential approvals of mRNA-1010 in markets worldwide; the immunogenicity and safety profile of mCOMBRIAX; the European Commission’s anticipated marketing authorization of mCOMBRIAX; and local access and implementation upon approval. In some cases, forward-looking statements can be identified by terminology such as “will,” “may,” “should,” “could,” “expects,” “intends,” “plans,” “aims,” “anticipates,” “believes,” “estimates,” “predicts,” “potential,” “continue,” or the negative of these terms or other comparable terminology, although not all forward-looking statements contain these words. The forward-looking statements in this press release are neither promises nor guarantees, and you should not place undue reliance on these forward-looking statements because they involve known and unknown risks, uncertainties, and other factors, many of which are beyond Moderna’s control and which could cause actual results to differ materially from those expressed or implied by these forward-looking statements. These risks, uncertainties, and other factors include, among others, those risks and uncertainties described under the heading “Risk Factors” in Moderna’s Annual Report on Form 10-K for the fiscal year ended December 31, 2025, filed with the U.S. Securities and Exchange Commission (SEC), and in subsequent filings made by Moderna with the SEC, which are available on the SEC’s website at www.sec.gov. Except as required by law, Moderna disclaims any intention or responsibility for updating or revising any forward-looking statements contained in this press release in the event of new information, future developments or otherwise. These forward-looking statements are based on Moderna’s current expectations and speak only as of the date of this press release.

    Moderna Contacts

    Media:

    Chris Ridley
    Vice President, Global Head of Communications
    +1 617-800-3651
    Chris.Ridley@modernatx.com

    Investors:

    Lavina Talukdar
    Senior Vice President & Head of Investor Relations
    +1 617-209-5834
    Lavina.Talukdar@modernatx.com

    [1]Immunogenicity and Safety of Influenza and COVID-19 Multicomponent Vaccine in Adults ≥50 Years: A Randomized Clinical Trial. JAMA: The Journal of the American Medical Association, published online 7 May 2025, https://jamanetwork.com/journals/jama/fullarticle/2833668

    SOURCE: Moderna, Inc.

    View the original press release on ACCESS Newswire

  • Atlas Salt Commences Site Preparation Activities

    ST GEORGE’S, NL / ACCESS Newswire / February 27, 2026 / Atlas Salt Inc. (“Atlas Salt” or the “Company”) (TSXV:SALT)(OTCQX:SALQF)(FRA:9D00) announces that it has fulfilled the applicable Environmental Assessment (“EA”) conditions necessary to initiate Early Works for the Great Atlantic Salt Project (the “Project”), located near St. George’s, Newfoundland and Labrador.

    Commencement of Land Clearing and Site Preparation Activities

    The Company confirms that:

    • The Early Works Development Plan and associated Environmental Management Plans have received approval from the Government of Newfoundland and Labrador, as previously disclosed.

    • The Benefits Agreement between Atlas Salt and the Province of Newfoundland and Labrador has been approved by necessary provincial entities, including Cabinet, and has been executed.

    • Atlas Salt has received a formal Letter of Release confirming satisfaction of the applicable Environmental Assessment conditions required to commence Early Works Phase activities.

    With these approvals and the Letter of Release in place, Atlas Salt is immediately commencing permitted land clearing and related site preparation activities.

    Transition to Site Activity

    Fulfillment of EA conditions for the Great Atlantic Salt Project represents a key regulatory milestone, enabling Atlas Salt to advance from permitting and planning into physical Early Works execution. Initial activities will include permitted land clearing, grubbing, and site preparation required to establish the mine site footprint and support subsequent construction phases.

    Nolan Peterson, President and CEO of Atlas Salt, commented:

    “With the execution of the Benefits Agreement with the Province of Newfoundland and Labrador and satisfaction of the Early Works conditions under our approved Environmental Assessment, we are now moving into site preparation and initial construction at the Great Atlantic Salt Project. Beginning construction is a major milestone achievement for any mining project. For Atlas and the Great Atlantic Salt Project, it reflects disciplined progress and growing momentum as we continue advancing the project toward full development and production.”

    Regulatory and Stakeholder Alignment

    Completion of the EA conditions and associated approvals reflects ongoing coordination with provincial regulators and stakeholders. The Benefits Agreement establishes a framework supporting employment, procurement, training, and community participation throughout the construction and operations phases of the Project. Atlas Salt will continue to advance required regulatory submissions as the Project progresses into subsequent phases.

    For further information and ongoing updates, please visit https://atlassalt.com.

    About Atlas Salt

    Atlas Salt is developing North America’s next salt mine and is committed to responsible and sustainable mining practices. With a focus on innovation and efficiency, the company is poised to make significant contributions to the North American salt market while upholding its values of environmental stewardship and community engagement.

    For information, please contact:

    Jeff Kilborn, CFO & VP Corporate Development
    investors@atlassalt.com
    (709) 275-2009

    We seek safe harbour.

    Cautionary Statement

    Neither the TSX Venture Exchange nor its Regulation Services Provider, (as the term is defined in the Policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release. This press release includes certain “forward-looking information” and “forward-looking statements” (collectively “forward-looking statements”) within the meaning of applicable Canadian securities legislation. All statements, other than statements of historical fact, included herein, without limitation, statements relating to the future operating or financial performance of the Company, are forward-looking statements. Forward-looking statements are frequently, but not always, identified by words such as “expects”, “anticipates”, “believes”, “intends”, “estimates”, “potential”, “possible”, and similar expressions, or statements that events, conditions, or results “will”, “may”, “could”, or “should” occur or be achieved. Forward-looking statements in this press release relate to, among other things: obtaining financing, completion, delivery and timing of project components and requirements, and analysis and assumptions related thereto. Actual future results may differ materially. There can be no assurance that such statements will prove to be accurate, and actual results and future events could differ materially from those anticipated in such statements. Forward-looking statements reflect the beliefs, opinions and projections on the date the statements are made and are based upon a number of assumptions and estimates that, while considered reasonable by the respective parties, are inherently subject to significant business, technical, economic, and competitive uncertainties and contingencies. Many factors, both known and unknown, could cause actual results, performance or achievements to be materially different from the results, performance or achievements that are or may be expressed or implied by such forward-looking statements and the parties have made assumptions and estimates based on or related to many of these factors. Such factors include, without limitation: the timing, completion and delivery of required permits, supply arrangements and financing. Readers should not place undue reliance on the forward-looking statements and information contained in this news release concerning these times. Except as required by law, the Company does not assume any obligation to update the forward-looking statements of beliefs, opinions, projections, or other factors, should they change, except as required by law.

    SOURCE: Atlas Salt Inc.

    View the original press release on ACCESS Newswire

  • ZTEST Electronics Inc. Announces Fiscal 2026 Q2 Results With 19% Year Over Year Revenue Growth

    NORTH YORK, ON / ACCESS Newswire / February 27, 2026 / ZTEST Electronics Inc. (“ZTEST” or the “Company“) (CSE:ZTE)(OTCID:ZTSTF) is pleased to announce Fiscal 2026 Q2 revenues of $2,481,516, an increase of 19% from the same period last year, with net income increasing over 104% to $425,913.

    Financial Highlights

    Three months ended

    (in thousands of dollars, except per share amounts)

    Dec 31
    2025

    Dec 31
    2024

    Revenue

    2,482

    2,081

    Gross Margin

    1,080

    830

    EBITDA

    661

    400

    Net Income

    426

    209

    Basic Net Income Per Share

    0.012

    0.006

    Operating Cash Flow

    510

    378

    As at

    (in thousands of dollars)

    Dec 31
    2025

    Dec 31
    2024

    Cash

    4,415

    3,679

    Working Capital

    5,872

    4,329

    Long-Term Debt

    23

    89

    Shareholders’ Equity

    6,532

    5,179

    CEO Steve Smith, commented, “While the electronics industry has been experiencing a cyclical slowdown, we have maintained our commitment to delivering top quality products and exceptional customer service. These efforts helped drive year-over-year revenue growth of more than 19% and the highest quarterly net income since June 30, 2024. We have also continued our growth of capital under management and consistently added to our strong liquidity position. We remain focused on building long-term shareholder value while keeping a disciplined approach to minimizing business risk.”

    About ZTEST Electronics Inc.
    ZTEST Electronics Inc., through its wholly owned subsidiary Permatech Electronics Corporation (“Permatech”), offers Electronic Manufacturing Services (EMS) to a wide range of customers. Permatech’s offering includes Printed Circuit Board (PCB) Assembly, Materials Management and Testing services. Permatech operates from an ISO 9001:2015 certified facility in North York, Ontario, Canada. Permatech is a contract assembler of complex circuit boards, serving customers in the Medical, Power, Computer, Telecommunications, Wireless, Industrial, Trucking, Wearables and Consumer Electronics markets. It specializes in servicing customers who are looking for high yield and require high quality and rapid-turnaround on low and mid-volume production of high complexity products.

    For more information contact: Steve Smith, CEO (604) 837-3751 email: steves@ztest.com

    Neither the Canadian Securities Exchange nor its Market Regulator (as that term is defined in the policies of the CSE) accepts responsibility for the adequacy or accuracy of this release.

    FORWARD LOOKING STATEMENTS: This press release contains forward looking statements, which relate to future events or future performance and reflect management’s current expectations and assumptions. Such forward looking statements reflect management’s current beliefs and are based on assumptions made by and information currently available to the Company. Investors are cautioned that these forward-looking statements are neither promises nor guarantees and are subject to risks and uncertainties that may cause future results to differ materially from those expected. These forward looking statements are made as of the date hereof and, except as required under applicable securities legislation, the Company does not assume any obligation to update or revise them to reflect new events or circumstances. All of the forward-looking statements made in this press release are qualified by these cautionary statements and by those made in our filings with SEDAR+ in Canada (available at www.sedarplus.com).

    SOURCE: ZTEST Electronics Inc.

    View the original press release on ACCESS Newswire

  • Horizon Aircraft to Participate in Upcoming Industry Events

    TORONTO, ONTARIO / ACCESS Newswire / February 27, 2026 / New Horizon Aircraft Ltd. (“Horizon Aircraft” or the “Company”) (NASDAQ:HOVR) announces that management of the Company will participate in the following upcoming events:

    Event: Prospectors & Developers Association of Canada (PDAC)

    Date: March 1-4, 2026

    Location: Toronto – Metro Toronto Convention Centre

    Event Link: https://pdac.ca/convention-2026

    The Company will be available for 1×1 meetings.

    Event: Verticon 2026

    Date: March 9-12, 2026

    Location: Atlanta – Georgia World Congress Center

    Event Link: https://verticon.org/

    The Company will be available for 1×1 meetings.

    Event: AIAC Aerospace on the Hill 2026

    Date: March 10-11, 2026

    Location: Ottawa – Parliament Hill

    The Company will engage in programming and connect with Canada’s top policy and decision-makers.

    Event: Quebec Air Transport Association 2026 Convention

    Date: March 18-20, 2026

    Location: Montréal – Marriott Château Champlain

    Event Link: https://www.aqta.ca/actualites/6155-congres-annuel-de-l-aqta-2026.html

    The Company will participate in a live panel discussion and will be available for informal conversations.

    Event: International Aerospace Innovation Forum

    Date: April 13-14, 2026

    Location: Montréal – Palais des congrès de Montréal

    Event Link: https://aeromontreal.ca/en/events/forum_innovation_2026-2/

    The Company will participate in a live panel discussion and will be available for informal conversations. The Company’s large-scale prototype will be showcased with team members present to engage in discussion.

    About Horizon Aircraft

    Horizon Aircraft (NASDAQ:HOVR) is an advanced aerospace engineering company that is developing one of the world’s first hybrid-electric VTOL (Vertical Take-Off and Landing) aircraft designed to fly most of its mission in traditional wing-borne flight, offering industry-leading speed, range, and operational utility. Horizon Aircraft’s unique designs put the mission first and prioritize safety and performance. Upon successful completion of testing and certification of its full-scale aircraft, Horizon Aircraft intends to scale unit production to meet expected demand from regional operators, emergency service providers, and military customers.

    For further information, visit:

    Website www.horizonaircraft.com
    LinkedIn https://www.linkedin.com/company/horizon-aircraft-inc

    For further information, contact:

    Investors:

    Kathryn Burns
    ir@horizonaircraft.com

    Media:

    Edwina Frawley-Gangahar
    EFG Media Relations
    +44 7580 174672
    edwina@efgmediarelations.com

    SOURCE: Horizon Aircraft

    View the original press release on ACCESS Newswire

  • GameSquare Announces 1.5 Million Share Repurchase

    FRISCO, TX / ACCESS Newswire / February 27, 2026 / GameSquare Holdings, Inc. (“GameSquare” or the “Company”) (NASDAQ:GAME), a next-generation media, entertainment, technology and digital native treasury company, today announced it repurchased over 1.5 million shares of its common stock during the month of February for $499,137, representing an average price of approximately $0.33 per share. Following this transaction, the Company has approximately $2.5 million remaining under its current authorization.

    Consistent with its capital allocation priorities, GameSquare intends to continue to opportunistically repurchase its common stock. Since October 2025, the Company has repurchased a total of 5.05 million shares of its common stock for $2.5 million, representing an average price of approximately $0.49 per share.

    “Despite ongoing volatility across the crypto and digital asset markets, GameSquare’s strategy is grounded in the strength and scale of our core operating business,” said Justin Kenna, CEO of GameSquare. “In the third quarter of 2025, our operating segments represented approximately 98% of total revenue and approximately 95% of gross profit, underscoring that we are first and foremost an operating company, not a proxy for digital asset prices. When combined with our yield-focused Digital Asset Treasury strategy, this foundation enables us to generate yield, manage risk, and deploy capital opportunistically, including through disciplined share repurchases.”

    About GameSquare Holdings, Inc.

    GameSquare (NASDAQ:GAME) is a cutting-edge media, entertainment, and technology company transforming how brands and publishers connect with Gen Z, Gen Alpha, and Millennial audiences. With a platform that spans award-winning creative services, advanced analytics, and FaZe Esports, one of the most iconic gaming organizations, we operate one of the largest gaming media networks in North America. As a digital-native business, GameSquare provides brands with unparalleled access to world-class creators and talent, delivering authentic connections across gaming, esports, and youth culture. Complementing our operating strategy, GameSquare has developed an innovative treasury management program designed to generate yield and enhance capital efficiency, reinforcing our commitment to building a dynamic, high-performing media company at the intersection of culture, technology, and next-generation financial innovation.

    To learn more, visit www.gamesquare.com.

    Forward-Looking Information

    This news release contains “forward-looking information” and “forward-looking statements” (collectively, “forward-looking statements”) within the meaning of the applicable securities legislation. All statements, other than statements of historical fact, are forward-looking statements and are based on expectations, estimates and projections as at the date of this news release. Any statement that involves discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, assumptions, future events or performance (often but not always using phrases such as “expects”, or “does not expect”, “is expected”, “anticipates” or “does not anticipate”, “plans”, “budget”, “scheduled”, “forecasts”, “estimates”, “believes” or “intends” or variations of such words and phrases or stating that certain actions, events or results “may” or “could”, “would”, “might” or “will” be taken to occur or be achieved) are not statements of historical fact and may be forward-looking statements. In this news release, forward-looking statements relate, among other things, to: the Company’s future performance, returns generated by its business strategies, revenue, growth and profitability; and the Company’s ability to execute on its current and future business plans. These forward-looking statements are provided only to provide information currently available to us and are not intended to serve as and must not be relied on by any investor as, a guarantee, assurance or definitive statement of fact or probability. Forward-looking statements are necessarily based upon a number of estimates and assumptions which include, but are not limited to: the Company’s ability to grow its business and being able to execute on its business plans and strategies, the success of Company’s vendors and partners in their provision of services to the Company, the Company being able to recognize and capitalize on opportunities and the Company continuing to attract qualified personnel to support its development requirements. These assumptions, while considered reasonable, are subject to known and unknown risks, uncertainties, and other factors which may cause the actual results and future events to differ materially from those expressed or implied by such forward-looking statements. Such factors include, but are not limited to: the Company’s annual meeting and corporate governance, its ability to achieve its objectives, the Company successfully executing its growth strategy, the ability of the Company to obtain future financings or complete offerings on acceptable terms, failure to leverage the Company’s portfolio across entertainment and media platforms, dependence on the Company’s key personnel and general business, economic, competitive, political and social uncertainties. These risk factors are not intended to represent a complete list of the factors that could affect the Company which are discussed in the Company’s most recent MD&A. There can be no assurance that forward-looking statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in such statements. Accordingly, readers should not place undue reliance on the forward-looking statements and information contained in this news release. GameSquare assumes no obligation to update the forward-looking statements of beliefs, opinions, projections, or other factors, should they change, except as required by law.

    Investor Relations
    Andrew Berger
    Phone: (216) 464-6400
    Email: ir@gamesquare.com

    Media Relations
    Chelsey Northern / The Untold
    Phone: (254) 855-4028
    Email: pr@gamesquare.com

    SOURCE: GameSquare Holdings, Inc.

    View the original press release on ACCESS Newswire

  • Dateline Acquires U.S. High-Grade heavy Rare Earths Project

    SAN BERNARDINO, CA / ACCESS Newswire / February 27, 2026 / Dateline Resources Limited (ASX:DTR)(OTCQB:DTREF)(FSE:YE1) (Dateline or the Company) is pleased to announce it has strategically acquired a new project, the Music Valley HREE Project (Music Valley), located in Riverside County, California, USA. Music Valley consists of 57 claims totaling 1,140 acres.

    Highlights

    • Music Valley heavy rare earths (HREE) acquisition: Dateline has secured the Music Valley HREE Project, comprising 57 claims over 1,140 acres in the Music Valley area of California.

    • HREE prospectivity: Historical United States Geological Survey (USGS) work describes HREE mineralization hosted in xenotime within the biotite-rich Pinto Gneiss, with a fractionated HREE signature.

    • Historical grades reported: USGS rock chip results reported 6.69%-15.04% TREO in the region, including high Yttrium and Dysprosium grades.

    • Rock Chip Sampling and Geophysics: The Company intends to undertake mapping, geochemistry and geophysics to define drill targets at Music Valley.

    • Strategic investment: As part of the acquisition terms, Dateline has completed a US$1.0 million investment in Fermi Critical Minerals Inc. (Fermi) intended to accelerate exploration across Fermi’s uranium and rare earth portfolio.

    • Scale and pipeline leverage: Fermi has eight projects at different stages of exploration and development, with a pipeline of catalysts across uranium and REE projects in the United States.

    Dateline’s Managing Director, Stephen Baghdadi, commented:

    Music Valley gives Dateline direct exposure to heavy rare earth mineralization in California with historically reported high-grade TREO results and strong heavy rare earth enrichment.

    “Our US$1 million investment in Fermi provides additional leverage to a substantial U.S. uranium and rare earth portfolio, including drill-permitted projects in Wyoming and Colorado.

    “This transaction enhances Dateline’s exposure to gold, uranium, light and heavy rare earths within the United States at a time when domestic supply chains are increasingly strategic.”

    Music Valley Heavy Rare Earths Project

    The project is located approximately eight miles southeast of Twentynine Palms in Riverside County, California and covers the main geological units and drainages highlighted in historical USGS sampling programs.

    Figure 1: Dateline Resources Project Location Plan, California

    Strategic Significance

    Rare Light rare earth elements (LREEs) such as neodymium and praseodymium are essential to high-performance permanent magnets used in electric vehicles, wind turbines and advanced motors. Heavy rare earth elements (HREEs) such as dysprosium and terbium enhance magnet strength and heat resistance and are critical to defence systems, advanced electronics and next-generation energy technologies, yet global production and processing remain heavily concentrated outside the United States.

    With supply chain security now a national priority, HREEs represent a strategic gap in the U.S. critical minerals landscape. Through its California rare earth portfolio, including the Music Valley Heavy Rare Earth Project and the Colosseum, located near the Mountain Pass rare earths mine, Dateline is positioning itself to contribute to both LREE and HREE demand growth while supporting a more secure and diversified domestic supply chain.

    Geological Setting

    Rare earth mineralization in the broader Music Valley area was first identified in 1954 by USGS geologists. USGS mapping shows the Music Valley area is underlain by Proterozoic to Palaeozoic metasedimentary rocks intruded by granitic and alkaline igneous bodies. These units are overlain locally by Tertiary volcanic and sedimentary sequences. Faulting and fracturing are widespread and control fluid movement and mineral deposition.

    USGS studies describe rare earth mineralisation associated with alkaline intrusive rocks, altered volcanic units, and reworked sedimentary materials. Heavy rare earth elements occur within accessory minerals such as xenotime, monazite, and other REE phosphates.

    Figure 2: Music Valley Claims outline

    USGS Rock Chip and Sample Results

    USGS rock chip and sediment sampling across Music Valley returned anomalous total rare earth element values with elevated proportions of heavy rare earths1. Several samples reported enrichment in dysprosium, terbium, yttrium, and ytterbium relative to light rare earth elements. The geochemical signature reflects fractionated rare earth systems consistent with heavy rare earth dominant mineralisation.

    Table 1: USGS rock chip sampling results from Pinto Gneiss in the region1

    Element

    Concentration (wt percent)

    Stoichiometric Equivalent (%)1

    Yttrium

    3.50 – 8.80% Y

    4.44 – 11.18% Y2O3

    Lanthanum

    0.26 – 0.34% La

    0.30 – 0.40% La2O3

    Cerium

    0.47 – 0.94% Ce

    0.55 – 1.10% CeO2

    Neodymium

    0.24 – 0.41% Nd

    0.28 – 0.48% Nd2O3

    Dysprosium

    0.22 – 0.41% Dy

    0.25 – 0.47% Dy2O3

    Ytterbium

    0.46 – 0.75% Yb

    0.52 – 0.85% Yb2O3

    Thorium

    0.31 – 0.49% Th

    0.35 – 0.56% ThO2

    TOTAL

    6.69 – 15.04% TREO

    1. Stoichiometric oxide equivalent calculated by multiplying the wt% of the element by the relevant conversion factor

    2. Sample locations not specified

    1 Evans, J.R., 1964, Xenotime mineralization in the southern Music Valley area, Riverside County, California: California Division of Mines and Geology Special Report 79, 24 p.

    Exploration Rationale

    Dateline’s exploration model for the Music Valley HREE Project focuses on:

    • Documented heavy rare earth enrichment from USGS sampling,

    • Favourable alkaline and altered host rocks,

    • Structural controls which concentrate mineralised fluids and sediments, and

    • Potential for near surface mineralisation.

    Planned Work

    In order to build up a ‘stacked evidence’ model prior to drilling, the initial work programs will include:

    • Detailed geological mapping,

    • Confirmatory rock chip and soil sampling,

    • Review and integration of historical USGS datasets, and

    • Geophysical surveys to define subsurface targets.

    Dateline considers the Music Valley area to be highly prospective and is working to expand the project area through further acquisitions and/or claim staking.

    The planned work program at the Music Valley Project will be funded from the existing cash balance of over $53M.

    Strategic investment in Fermi Critical Minerals Inc.

    As part of the acquisition terms of the Music Valley HREE Project, Dateline has completed a US$1.0 million strategic equity investment in Fermi. Fermi is raising a total of US$4 million from investors. On completion of the capital raise by Fermi, Dateline will own four million shares out of a total of approximately 45 million shares on issue. Fermi intends to use the funds to accelerate exploration across its U.S. mining portfolio, including drilling on priority uranium targets, additional geophysical surveys, systematic sampling on rare earth properties, technical/modelling work and working capital/regulatory advancement.

    Further details on the Fermi project portfolio can be found at https://fermiuranium.com/

    Transaction Summary – Total outlay of US$1.05M

    Component

    What Dateline secured

    Key attributes

    Music Valley HREE Project (California)

    100% of the Music Valley claim package

    57 claims; 1,140 acres; HREE prospectivity; xenotime-hosted mineralization within Pinto Gneiss; historical USGS results reported up to 15.04% TREO

    Strategic equity investment in Fermi Critical Minerals Inc.

    (U.S. uranium & REE portfolio)

    4 million Fully Paid Ordinary shares in Fermi, exposure to a multi-asset project portfolio

    Eight projects 785 federal claims; 11 Wyoming State leases; drill-permitted/near-permitted assets including New Fork Valley & Pitchfork

    Additional Gold Upside Potential

    The Music Valley area was also historically mined for gold, with dozens of small-scale adits and shafts developed in the area. Most of this activity occurred prior to 1920 so there is only limited information available with regards to tonnes and grade. Whilst rare earths will be the primary target at Music Valley, mapping, rock chip sampling and geochemistry will also assess the gold potential of the region.

    Figure 3 shows the historic gold prospects in the Mindat database.

    Figure 3: Historical Gold Prospects (source mindat.org)

    This press release has been authorized for release by the Board of Dateline Resources Limited.

    For more information, please contact:

    Stephen Baghdadi
    Managing Director
    +61 2 9375 2353

    Andrew Rowell
    Corporate & Investor Relations Manager
    +61 400 466 226
    a.rowell@dtraux.com
    www.datelineresources.com.au

    Follow Dateline on socials:
    X – @Dateline_DTR
    Truth Social – @dateline_resources
    LinkedIn – dateline-resources
    YouTube – @dateline.resources

    About Dateline Resources Limited

    Dateline Resources Limited (ASX:DTR)(OTCQB:DTREF)(FSE:YE1) is an Australian company focused on mining and exploration in North America. The Company owns 100% of the Colosseum Gold-REE Project in California.

    The Colosseum Gold Mine is located in the Walker Lane Trend in East San Bernardino County, California. On 6 June 2024, the Company announced to the ASX that the Colosseum Gold mine has a JORC-2012 compliant Mineral Resource estimate of 27.1Mt @ 1.26g/t Au for 1.1Moz. Of the total Mineral Resource, 455koz @ 1.47/t Au (41%) are classified as Measured, 281koz @1.21g/t Au (26%) as Indicated and 364koz @ 1.10g/t Au (33%) as Inferred.

    On 23 May 2025, Dateline announced that updated economics for the Colosseum Gold Project generated an NPV6.5 of US$550 million and an IRR of 61% using a gold price of US$2,900/oz.

    The Colosseum is located less than 10km north of the Mountain Pass Rare Earth mine. Planning has commenced on drill testing the REE potential at Colosseum.

    Dateline owns 100% of the high-grade Argos Strontium Project, also located in San Bernadino County, California. Argos is reportedly the largest strontium deposit in the U.S. with previous celestite production grading 95%+ SrSO4.

    In February 2026, Dateline announced the acquisition of the Music Valley Heavy Rare Earth Project in Riverside County, California. The region has known HREE mineralisation from USGS rock chip sampling, however it has not been subjected to modern exploration techniques.

    Forward-Looking Statements

    This announcement may contain “forward-looking statements” concerning Dateline Resources that are subject to risks and uncertainties. Generally, the words “will”, “may”, “should”, “continue”, “believes”, “expects”, “intends”, “anticipates” or similar expressions identify forward-looking statements. These forward-looking statements involve risks and uncertainties that could cause actual results to differ materially from those expressed in the forward-looking statements. Many of these risks and uncertainties relate to factors that are beyond Dateline Resources’ ability to control or estimate precisely, such as future market conditions, changes in regulatory environment and the behavior of other market participants. Dateline Resources cannot give any assurance that such forward-looking statements will prove to have been correct. The reader is cautioned not to place undue reliance on these forward-looking statements. Dateline Resources assumes no obligation and does not undertake any obligation to update or revise publicly any of the forward-looking statements set out herein, whether as a result of new information, future events or otherwise, except to the extent legally required.

    Competent Person Statement

    Sample preparation and any exploration information in this announcement is based upon work reviewed by Mr. Greg Hall who is a Chartered Professional of the Australasian Institute of Mining and Metallurgy (CP-IMM). Mr. Hall has sufficient experience that is relevant to the style of mineralization and type of deposit under consideration and to the activity which he is undertaking to qualify as a Competent Person as defined in the 2012 Edition of the “Australasian Code for Reporting Exploration Results, Mineral Resources and Ore Reserves” (JORC Code). Mr. Hall is a Non-Executive Director of Dateline Resources Limited and consents to the inclusion in the report of the matters based on this information in the form and context in which it appears.

    Company Confirmations

    The Company confirms it is not aware of any new information or data that materially affects the information included in the announcements dated 23 October 2024 with regard to the Colosseum MRE and 23 May 2025 with regard to Colosseum Project Economics. Similarly, the Company confirms that all material assumptions and technical parameters underpinning the estimates and the forecast financial information referred to in those previous announcements continue to apply and have not materially changed.

    SOURCE: Dateline Resources Limited

    View the original press release on ACCESS Newswire

  • Canada’s Office-to-Residential Revolution: How Adaptive Reuse Is Reshaping Urban Housing

    Toronto’s skyline continues to evolve as office-to-residential conversions gain momentum.

    TORONTO, ONTARIO / ACCESS Newswire / February 27, 2026 / As Canada’s major cities grapple with a dual crisis – a deepening housing shortage and a glut of vacant downtown office towers – a growing number of developers and policymakers are turning to a powerful, underutilized solution: adaptive reuse. The conversion of commercial office buildings into residential units is emerging as one of the most promising strategies to accelerate housing supply while revitalizing urban cores that have struggled since the pandemic reshuffled workplace habits.

    Ladan Hosseinzadeh Sadeghi, President & CEO of Sky Property Group Inc., has been watching this trend closely – and believes it represents one of the defining real estate opportunities of the decade.

    “Canada is sitting on a tremendous untapped asset,” said Ladan Hosseinzadeh Sadeghi. “We have millions of square feet of underperforming office inventory in cities like Toronto, Calgary, Ottawa, and Vancouver, and at the same time, we have hundreds of thousands of families who cannot find an affordable place to live. Adaptive reuse isn’t just creative development – it’s common sense urban planning.”

    The Scale of the Problem – and the Opportunity

    According to data from CBRE Canada, national office vacancy rates in 2025 reached their highest levels in over three decades, hovering near 18% nationally and exceeding 25% in some downtown submarkets. Calgary, long battered by the oil and gas sector’s volatility, has led the country in office-to-residential conversions, with more than 20 projects already completed or underway through its Downtown Development Incentive Program.

    Toronto, Canada’s largest city and a global financial hub, is beginning to follow suit. With downtown office vacancy climbing above 17% and the city facing a projected shortfall of more than 285,000 housing units over the next decade, the case for conversion has never been stronger.

    “The fundamentals are aligning,” said Ladan Hosseinzadeh Sadeghi of Sky Property Group. “You have distressed asset owners who need an exit, municipalities desperate for housing supply, and a federal government finally willing to remove GST on new purpose-built residential conversions. This is the moment developers need to move strategically.”

    Office towers across Canada are being reimagined as residential communities through adaptive reuse.

    Federal Policy Is Opening the Door

    The federal government’s decision to eliminate the Goods and Services Tax (GST) on the conversion of commercial properties to residential use – first announced in late 2023 and refined through subsequent budgets – has been a catalyst for renewed developer interest. The policy applies to projects where buildings are substantially renovated and converted, making previously marginal projects financially viable.

    Several provinces have followed with their own complementary incentives. Ontario has streamlined certain permitting pathways for adaptive reuse applications, while British Columbia has introduced density bonusing programs to encourage mixed-use conversions in transit-adjacent corridors.

    “Government incentives matter enormously, but they only work if the private sector is ready to execute,” noted Ladan Hosseinzadeh Sadeghi. “At Sky Property Group, we’ve spent years developing the land assembly and zoning expertise that positions us to move quickly on opportunities like this. Speed and precision are competitive advantages in adaptive reuse.”

    The Development Challenges Are Real – and Solvable

    Office-to-residential conversion is not without its complexities. Structural differences between commercial and residential buildings – including floor plate depths, core placement, plumbing infrastructure, and natural light access – can make conversions technically challenging and expensive. Deep-floorplate buildings, common in 1970s and 1980s office towers, can be particularly difficult to adapt into livable residential suites.

    Yet innovative developers are finding solutions. Some projects are carving interior courtyards into existing buildings to bring natural light to central units. Others are using creative floor plan configurations – such as micro-suites, co-living models, and hybrid commercial-residential uses at grade – to maximize the viability of otherwise awkward floor plans.

    “The engineering challenges are real, but they’re not insurmountable,” said Ladan Hosseinzadeh Sadeghi. “Every building has its own fingerprint. The key is doing rigorous due diligence on the front end – structural assessments, mechanical feasibility, zoning analysis – so you’re not discovering problems after you’ve committed capital. We’ve built our process around that discipline.”

    She added that working closely with municipal planning departments early in the process is essential. “Adaptive reuse projects that succeed are the ones where the developer and the city are genuinely aligned on outcomes. We’re not just building units – we’re helping cities reimagine what their downtowns can be.”

    Strategic planning and rigorous due diligence are central to successful adaptive reuse projects.

    A Path to Diverse Housing Typologies

    One of the underappreciated benefits of office-to-residential conversion is the potential to deliver housing typologies that the market sorely needs. Rather than adding more luxury condominiums to already saturated towers, adaptive reuse projects can be designed to deliver rental units at a range of price points, including affordable and below-market units, particularly when paired with public subsidies or non-profit partners.

    The Canada Mortgage and Housing Corporation (CMHC) has increasingly recognized this, expanding access to its low-cost financing programs – including the Apartment Construction Loan Program and the Affordable Housing Fund – to include qualifying adaptive reuse projects. This access to patient capital at concessional rates can dramatically improve project economics.

    “What excites me most about adaptive reuse is the chance to add genuine diversity to Canada’s housing stock,” said Ladan Hosseinzadeh Sadeghi. “We’ve been stuck in a condo-heavy development cycle for too long. Converting office towers gives us the chance to deliver rental apartments, affordable units, and family-sized suites that Canadian cities desperately need. That’s a legacy worth building.”

    Converted office spaces can deliver distinctive residential lofts with generous windows and unique character.

    Looking Ahead: A New Chapter for Canadian Urban Cores

    As remote and hybrid work continue to reshape demand for commercial space, the wave of office-to-residential conversion is expected to accelerate through the late 2020s. Cities from Halifax to Victoria are exploring how to update zoning bylaws, streamline approvals, and design incentive programs that make conversions attractive to private capital.

    For developers like Sky Property Group Inc., the opportunity is clear – but so is the responsibility.

    “Canada’s housing crisis didn’t happen overnight, and it won’t be solved overnight,” said Ladan Hosseinzadeh Sadeghi. “But adaptive reuse is one of the fastest, most impactful tools we have. It takes existing buildings, existing infrastructure, and existing urban fabric – and it transforms them into homes. That’s what this industry should be doing right now.”

    About Sky Property Group Inc.

    Sky Property Group Inc. is a Toronto-based real estate development and property management company specializing in strategic land assembly, urban intensification, and high-density residential development across the Greater Toronto Area and beyond. Led by President & CEO Ladan Hosseinzadeh Sadeghi, the company is committed to creating sustainable, community-focused development that addresses Canada’s evolving housing needs.

    Contact Information

    Ladan Hosseinzadeh Sadeghi
    ladanhosseinzadehsadeghi@gmail.com

    SOURCE: Sky Property Group Inc.

    View the original press release on ACCESS Newswire

  • 60 Degrees Pharmaceuticals and BioVie Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV

    ORLANDO, FL / ACCESS Newswire / February 27, 2026 / RedChip Companies will air interviews with 60 Degrees Pharmaceuticals, Inc. (NASDAQ:SXTP) and BioVie, Inc. (NASDAQ:BIVI) on the RedChip Small Stocks, Big Money™ show, a sponsored program on Bloomberg TV this Saturday, February 28, at 7 p.m. Eastern Time (ET). Bloomberg TV is available in an estimated 73 million homes across the U.S.

    Access the interviews in their entirety at:

    Geoffrey Dow, PhD, CEO of 60 Degrees Pharmaceuticals, appears on the RedChip Small Stocks Big Money™ show on Bloomberg TV to discuss the Company’s mission to combat infectious diseases with innovative, small-molecule therapeutics. Dr. Dow will highlight the potential of ARAKODA® (tafenoquine), an FDA-approved antimalarial developed with the U.S. Army, and its expanding commercial footprint in the U.S. He will also outline the company’s plan to expand FDA approval for tafenoquine to babesiosis-a growing tick-borne illness, incidence of which management believes is vastly underrepresented by CDC estimates and for which there is no FDA-approved therapy. 60 Degrees Pharmaceuticals has two clinical trials (hospitalized babesiosis patients and relapsing patients) underway, and initiation of a third planned near-term. 60 Degrees Pharmaceuticals has Orphan Drug status for tafenoquine for babesiosis and patent exclusivity for the malaria indication through 2035.

    Cuong Do, President and CEO of BioVie, appears on the RedChip Small Stocks Big Money™ show on Bloomberg TV to discuss bezisterim (NE3107), BioVie’s first-in-class, orally available small molecule that targets inflammation and insulin resistance, two key drivers of Alzheimer’s, Parkinson’s, and Long COVID, where it has shown encouraging signals of improved cognition, motor function, and reduced neuroinflammation across clinical studies. He will also outline progress with BIV201, BioVie’s late-stage orphan drug candidate for refractory ascites, a life-threatening complication of liver cirrhosis with no FDA-approved therapies. With multiple late-stage clinical programs advancing, strong safety data, and multi-billion-dollar market opportunities, BioVie is positioned to deliver significant value creation as it approaches pivotal milestones and potential partnerships.

    SXTP and BIVI are clients of RedChip Companies. Please read our full disclosure at https://www.redchip.com/legal/disclosures.

    About 60 Degrees Pharmaceuticals, Inc.

    60 Degrees Pharmaceuticals, Inc., founded in 2010, specializes in developing and commercializing new medicines for the treatment and prevention of vector-borne disease. The Company achieved U.S. Food and Drug Administration approval of Its lead product, ARAKODA® (tafenoquine), for malaria prevention, in 2018. ARAKODA is commercially available in the U.S. and Australia. 60 Degrees Pharmaceuticals, Inc. also collaborates with prominent research and academic organizations in the U.S. and Australia. 60 Degrees Pharmaceuticals, Inc. is headquartered in Washington, D.C., with a subsidiary in Australia. Learn more at www.60degreespharma.com.

    About BioVie, Inc.

    BioVie Inc. (NASDAQ: BIVI) is a clinical-stage biopharmaceutical company focused on developing therapies for neurological disorders and advanced liver disease. Its lead candidate, bezisterim (NE3107), targets neuroinflammation and insulin resistance, which are believed to be key drivers of Alzheimer’s and Parkinson’s disease. Bezisterim is also being studied for long COVID, where persistent inflammation is thought to underlie symptoms such as brain fog and fatigue.

    In liver disease, BioVie is advancing BIV201, a continuous infusion of terlipressin treatment that has received FDA Orphan and Fast Track designations. The active agent is approved in the U.S. and in about 40 countries for related complications of advanced liver cirrhosis, and the Company plans to study BIV201 in a Phase 3 trial for the reduction of further decompensation in patients with cirrhosis and ascites. For more information, visit www.bioviepharma.com.

    About RedChip Companies

    RedChip Companies, an Inc. 5000 company, is an international investor relations, media, and research firm focused on microcap and small-cap companies. Founded in 1992 as a small-cap research firm, RedChip gained early recognition for initiating coverage on emerging blue chip companies such as Apple, Starbucks, Daktronics, Winnebago, and Nike. Over the past 34 years, RedChip has evolved into a full-service investor relations and media firm, delivering concrete, measurable results for its clients, which have included U.S. Steel, Perfumania, Cidara Therapeutics, and Celsius Holdings, among others. Our newsletter, Small Stocks, Big Money™, is delivered online weekly to 60,000 investors. RedChip has developed the most comprehensive service platform in the industry for microcap and small-cap companies. These services include the following: a worldwide distribution network for its stock research; retail and institutional roadshows in major U.S. cities; outbound marketing to stock brokers, RIAs, institutions, and family offices; a digital media investor relations platform that has generated millions of unique investor views; investor webinars and group calls; a television show, Small Stocks, Big Money™, which airs weekly on Bloomberg US; TV commercials in local and national markets; corporate and product videos; website design; and traditional investor relation services, which include press release writing, development of investor presentations, quarterly conference call script writing, strategic consulting, capital raising, and more. RedChip also offers RedChat™, a proprietary AI-powered chatbot that analyzes SEC filings and corporate disclosures for all Nasdaq and NYSE-listed companies, giving investors instant, on-demand insights.

    To learn more about RedChip’s products and services, please visit:

    https://www.redchip.com/corporate/investor_relations

    “Discovering Tomorrow’s Blue Chips Today”™

    Follow RedChip on LinkedIn: https://www.linkedin.com/company/redchip/
    Follow RedChip on Facebook: https://www.facebook.com/RedChipCompanies
    Follow RedChip on Instagram: https://www.instagram.com/redchipcompanies/
    Follow RedChip on Twitter: https://twitter.com/RedChip
    Follow RedChip on YouTube: https://www.youtube.com/@redchip
    Follow RedChip on Rumble: https://rumble.com/c/c-3068340

    Subscribe to our Mailing List: https://www.redchip.com/newsletter/latest

    Contact:

    Dave Gentry
    RedChip Companies Inc.
    1-800-REDCHIP (733-2447)
    1-407-644-4256
    info@redchip.com

    SOURCE: RedChip Companies, Inc.

    View the original press release on ACCESS Newswire

  • 75 Years of Building Facilities That Endure Founded in 1951 by a WWII Veteran, Speed Fab Crete Corp Celebrates Design-Build Excellence

    Excellence in Design-Build, General Construction, and Precast, Expertise in ICC 500 Storm-Shelters

    FORT WORTH, TX / ACCESS Newswire / February 27, 2026 / Speed Fab Crete Corp, a Texas-based construction, manufacturing, and design-build contractor founded in 1951 by Dave Bloxom, Sr., a WWII Veteran, announced this month that it is celebrating 75 years of continuous operations in 2026, marking a significant milestone in the company’s history and the construction industry across the Southwest.

    To date, Speed Fab Crete has delivered more than 1,000 projects across the Southwest, including Texas and Oklahoma, over seven decades. Many of these facilities remain in service today, some for more than 40 years, reflecting the company’s long-standing commitment to durability, quality, and long-term performance.

    A defining chapter in the company’s history began in 1998, when a new ownership era was established under David Bloxom Jr., Ronald A. Hamm, and Carl Hall, who continue to lead the company today as Chairman of the Board and co-owner, President and co-owner, and Vice President and Executive Director of Precast, respectively. That transition marked the beginning of sustained modernization, strategic investment, and expansion of the company’s design-build and manufacturing capabilities.

    Today, Speed Fab Crete operates a 15-acre manufacturing facility in Kennedale, near Dallas-Fort Worth, employing more than 150 professionals across engineering, manufacturing, construction, and administration. The company is widely recognized as a leading design-build contractor and precast concrete manufacturer, serving commercial, educational, municipal, public safety, automotive, and infrastructure markets.

    The company’s manufacturing facility is a Certified Plant by the National Precast Concrete Association, the American Precast Association, and the Concrete Certification Institute, a designation awarded to only a small percentage of precast producers nationwide and reflective of Speed Fab Crete’s ability to consistently deliver high-quality concrete systems.

    Speed Fab Crete Corp also recognizes Classic Chevrolet and the Classic Family of Dealerships as valued clients for more than 50 years, representing one of Speed Fab Crete’s longest and most trusted client partnerships.

    Recent and ongoing projects include Classic Honda of Midland, Texas, and the City of Josephine Public Safety and Municipal Facilities Program, both completed in 2025; the City of Rowlett Fire and Police Station No. 5 (Sapphire Bay), February 2026; and ongoing image upgrades for Honda and Chevrolet.

    Additional notable projects include precast concrete work by Speed Fab Crete Corp for the TCU stadium addition, reflecting a long-standing connection to Texas Christian University, where the company’s founder attended and later donated the stadium scoreboard in support of the university. The Greenwood Remembrance Center at Greenwood Funeral Home in Fort Worth is also recognized as a signature project for its craftsmanship, architectural character, and lasting contribution to the community.

    In addition to these projects, Speed Fab Crete continues to specialize in the design and construction of ICC 500-compliant precast storm shelters for school districts and public facilities. For more than a decade, the company has delivered these life-safety structures aggressively, supporting public safety, resilience, and community preparedness.

    Speed Fab Crete Corp is deeply committed to community engagement, contributing thousands of dollars annually to charitable organizations and local causes. The company supports organizations, including the Genesis Center of North Texas and the Tom and Susan Durant Foundation, and plans additional community- and employee-focused initiatives throughout the anniversary year.

    “Seventy-five years reflects the dedication of our people and the trust our clients place in us,” said Ronald A. Hamm, President of Speed Fab Crete Corp. “We believe our success has been driven largely by customer recommendations and long-term relationships built by treating people with respect, fairness, and integrity. That approach continues to guide how we serve our clients, partners, and communities while building facilities that endure.”

    About Speed Fab Crete Corp
    Speed Fab Crete Corp is a construction, manufacturing, and design-build contractor specializing in precast concrete solutions and integrated design and construction services for commercial, educational, municipal, and infrastructure projects. Founded in 1951, the company is celebrating its 75th year of continuous operations and is recognized for its commitment to quality, safety, durability, and regulatory compliance.

    For more than seven decades, Speed Fab Crete Corp has maintained compliance with evolving federal, state, and local laws and governmental requirements, continuously adapting its policies, internal controls, and operational practices to align with changing regulatory frameworks. The company is also widely regarded as an employer of choice, valued for its workplace culture and long-term investment in its workforce.

    In addition to its core operations, Speed Fab Crete Corp is a recognized leader in the design and construction of ICC 500-compliant storm shelters, which are built to sustain winds of an EF-5 Tornado, up to 250 MPH, for school districts and public facilities, supporting life safety, community resilience, and public preparedness across the regions it serves.

    Media Contact:
    Trina H. Torres
    Corporate Communications
    Speed Fab Crete Corp
    817-478-1137
    ttorres@speedfabcrete.com

    SOURCE: Speed Fab Crete

    View the original press release on ACCESS Newswire

  • ZetrOZ Systems Extends Its Non-Invasive Knee Osteoarthritis Treatment to Orthopaedic Surgeons Across the United States

    The active-aging healthcare innovators will showcase the sustained acoustic medicine device’s effectiveness in treating knee osteoarthritis and soft tissue injuries, reducing pain and the need for invasive surgery.

    TRUMBULL, CT / ACCESS Newswire / February 27, 2026 / ZetrOZ Systems will showcase its sam® sustained acoustic medicine technology’s effectiveness in treating knee osteoarthritis and other musculoskeletal conditions at the annual meeting of the American Academy of Orthopaedic Surgeons, March 3-5, in New Orleans.

    The company will provide clinical information and demonstrate the sam® wearable ultrasound device at Booth 3612 in Hall E of the Ernest N. Morial Convention Center.

    ZetrOZ Systems also is hosting AAOS conference attendees at an education event, Sam on the Rocks, at the Old Absinthe House’s Prohibition Room at 240 Bourbon Street, from 5:00 p.m. to 7:00 p.m. on Tuesday, March 3.

    Orthopaedic leaders and clinicians will learn how ZetrOZ Systems’ wearable ultrasound technology has been integrated into real-world clinical practice. Attendees will also discover how the sam® units are helping shape the future of orthopaedic and sports medicine care.

    Sustained acoustic medicine, via the sam® device, is continuous, high-frequency, long-duration ultrasound treatment applied directly to the site of an injury, increasing blood vessel diameters to improve blood flow. This increases oxygenated hemoglobin at the site and removes cytokine enzymes and cellular waste, resulting in more rapid healing and reduced pain.

    The effectiveness of ZetrOZ Systems’ technology has been validated in 42 peer-reviewed basic science, engineering and clinical publications and 20 Level 1-5 clinical studies. One study, published in the Journal of Orthopaedic Surgery and Research, found that “Sustained acoustic medicine (sam®), a multi-hour treatment, has demonstrated improved clinical outcomes for patients with knee OA.”

    The study concluded that “the sam® wearable home-use continuous long-duration ultrasound appears to be a cost-effective therapy and should be considered when treating patients with knee OA.”

    More than 3.7 million patient treatments demonstrate that ZetrOZ Systems’ sustained acoustic medicine and the sam® wearable ultrasound devices reduce pain, improve function, and help people return to sports and daily activities. For more information about ZetrOZ Systems and the sam® wearable ultrasound device, visit www.zetroz.com or www.samrecover.com.

    About ZetrOZ Systems

    ZetrOZ Systems is a leader in sports medicine innovation, developing wearable bioelectronic devices that deliver sustained acoustic medicine (sam®). Researched and funded by the federal government, ZetrOZ is built on proprietary medical technology protected by 46 patents and is the exclusive manufacturer and developer of the sam® product line, designed to treat acute and chronic musculoskeletal conditions.

    Media Contact

    Catherine Hoblin
    choblin@zetroz.com

    SOURCE: ZetrOZ Systems

    View the original press release on ACCESS Newswire